← Back to Search

Self-Care Support Tools for Oral Cancer Survivors

N/A
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age > 18 years
Currently cancer free (but can have experienced a recurrence)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, two and 6 months post-baseline
Awards & highlights

Study Summary

This trial will compare the Empowered Survivor online tool against the Springboard Beyond Cancer intervention to see which is more effective for cancer survivors.

Who is the study for?
This trial is for English-reading adults over 18 who are currently cancer-free, even if they've had a recurrence. They must have been diagnosed with their first invasive oral or oropharyngeal cancer between 1 and 3 years ago, have internet access, and be able to read surveys and online content.Check my eligibility
What is being tested?
The study compares an online tool called Empowered Survivor (ES) created by the research team with Springboard Beyond Cancer, another free online self-management tool developed for cancer survivors. Participants will use these tools and complete surveys.See study design
What are the potential side effects?
Since this trial involves using online self-care management tools rather than medications or medical procedures, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am currently cancer-free, though I may have had cancer before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, two and 6 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, two and 6 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Preparedness for survivorship
Quality of Life score measured using the The European Organization for Research and Treatment of Cancer (EORTC)- Head and Neck
Self-efficacy score
Secondary outcome measures
Comprehensiveness is the number of areas checked (11 areas) during the oral self-exam
Performance of exercises to improve swallowing, past month (yes/no)
Performance of head/neck exercises, past month (yes/no)
+1 more
Other outcome measures
Action and Planning Coping
Concerns about recurrence scale
Information Needs
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Empowered Survivor onlineExperimental Treatment2 Interventions
The online intervention, called Empowered Survivor (ES) is a self-management intervention for patients with head and neck cancer. The intervention contains the following modules: Introduction; Difficulty Swallowing and Muscle Strength; Oral Care; Long-term Follow-Up Care/Oral exams; Calm and Connect; and Maintaining.
Group II: Springboard Beyond CancerActive Control2 Interventions
Springboard Beyond Cancer is a general resource for survivors of all cancer. It is a free self-management program for cancer survivors developed by trusted sources, the ACS and the NCI.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
63,632 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,254 Total Patients Enrolled
7 Trials studying Oral Cancers
1,153 Patients Enrolled for Oral Cancers
The Cancer Registry of Greater CaliforniaUNKNOWN

Media Library

Empowered Survivor Online Clinical Trial Eligibility Overview. Trial Name: NCT04713449 — N/A
Oral Cancers Research Study Groups: Empowered Survivor online, Springboard Beyond Cancer
Oral Cancers Clinical Trial 2023: Empowered Survivor Online Highlights & Side Effects. Trial Name: NCT04713449 — N/A
Empowered Survivor Online 2023 Treatment Timeline for Medical Study. Trial Name: NCT04713449 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary goal of this experiment?

"The primary objective of this clinical trial, measured over baseline and two-monthly intervals up to 6 months post-baseline is assessing the preparedness for survivorship. A secondary outcome includes ascertaining a change in comprehensiveness of exams over time via an 11 item survey with participants indicating if they checked each area during the oral self-exam or not. Additionally, performance of exercises to improve swallowing and head/neck dexterity will be monitored on a monthly basis to measure efficacy of the intervention."

Answered by AI

To what extent is this study accommodating participants?

"Affirmative. Data from clinicaltrials.gov indicates that this medical trial is actively recruiting and was initially posted on January 19th 2021 with the most recent update taking place July 27th 2022. 600 volunteers are needed for research at one site."

Answered by AI

To whom would this clinical experiment be most beneficial?

"This clinical trial is targeting 600 people aged 18-89 who were recently diagnosed with an oropharyngeal cancer and are currently in remission. To be eligible, participants must know how to read English, possess internet connectivity and adequate vision for survey completion."

Answered by AI

Is this experiment presently recruiting participants?

"Clinicaltrials.gov has the most up-to-date information regarding this trial, which was initially advertised on January 19th 2021 and recently revised on July 27th 2022. At present, it is actively enrolling patients."

Answered by AI

Are the requirements for participation in this research limited to individuals over 65 years of age?

"The parameters for entry into this trial require that applicants range from 18 to 89 years of age. There are 19 studies listed specifically for patients under the legal age and an additional 429 trials open to seniors aged 65 or older."

Answered by AI
~122 spots leftby Mar 2025